Table 88. Medical eligibility criteria (modified)* and index of effectiveness for contraceptive use in patients with valve disease220,221.
| Available contraceptives | Oral CHC | Monthly injection | Progesterone pills | InjecTable progesterone | Implantation of progesterone | Copper IUD | Levonorgestrel IUD |
|---|---|---|---|---|---|---|---|
| Valve disease | |||||||
| Not complicated | 2 | 1 | 1 | 1 | 1 | 3/4 | 3/4 |
| Prognostic factors | 4 | 4 | 1 | 1 | 1 | 4 | 4 |
| Effectiveness | 8 | 3 | 3 | 3 | 0.05 | 0.8 | 0.1 |
*
Prognostic factors: Effectiveness (Pearl Index) calculated as the number of pregnancies per 100 women who routinely use the method. Eligibility criteria: category 1: there are no restrictions to using the method; category 2: the advantages of using the method generally outweigh the theoretical or proven risks; category 3: the theoretical or generally proven risks outweigh the advantages of using the method; category 4: condition that represents an unaccepTable health risk of using the contraceptive method. CHC: combined hormonal contraceptive; IUD: intrauterine device.